Navigation Links
The Lustgarten Foundation Says Patrick Swayze's Death Highlights the Need for Increased Research into Early Diagnosis and Treatment of Pancreatic Cancer
Date:9/15/2009

BETHPAGE, N.Y., Sept. 15 /PRNewswire/ -- The Lustgarten Foundation, the nation's largest private supporter of research into better detection and treatment of pancreatic cancer, today issued the following statement on the disease that took actor Patrick Swayze's life.

Kerri Kaplan, Lustgarten Foundation Executive Director, said: "We all mourn the death of beloved actor Patrick Swayze. His courageous, public battle with pancreatic cancer serves as an inspiration for anyone suffering from a life-threatening disease. It reminded us that pancreatic cancer is the most lethal cancer there is -- even for someone as fit and positive as Mr. Swayze. His loss underscores the fact that our only weapon against this disease, which has a survival rate of just 5 percent, is a continued commitment to funding research that will enhance our understanding of pancreatic cancer, improve early diagnosis and treatment options, and one day, lead us to a cure. We will not back down from the battle against pancreatic cancer. Patrick Swayze never did. We are all deeply saddened by his death."

About The Lustgarten Foundation and Pancreatic Cancer

The Lustgarten Foundation, based in Bethpage, New York, is America's largest private foundation working solely on pancreatic cancer research. The Foundation provides critical support in the search for better diagnostics and treatment of pancreatic cancer, and to date has provided more than $22 million to more than 110 research projects at some of the world's most prestigious medical and research centers.

The Lustgarten Foundation and Cablevision Systems Corporation, a leading media and entertainment company, together launched curePC, a public awareness campaign that uses Cablevision's high-profile assets to draw attention to the fight against pancreatic cancer. As part of this campaign, Cablevision made a multi-year commitment to underwrite all of The Lustgarten Foundation's administrative costs to ensure that 100 percent of every dollar donated to The Foundation will go directly to pancreatic cancer research. To learn more, visit www.curepc.org.


'/>"/>
SOURCE The Lustgarten Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lustgarten Foundation Announces 2009 Request for Proposals (RFP)
2. Sopranos Star Vincent Pastore Wins 50 Big Ones for Lustgarten Foundation on NBCs The Celebrity Apprentice
3. Sudden Cardiac Arrest Foundation Kicks Off You Can Save A Life Video Awareness Contest on YouTube(TM)
4. Former Make A Wish Kid Donates September Earnings to the Global Foundation
5. Crohn's & Colitis Foundation Issues Annual Report
6. Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation
7. In Letter to President, TPC Highlights Foundation Grants in Health
8. Peter G. Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and Higher Costs
9. Alzheimers Drug Discovery Foundation Funds Abiant, Inc. to Develop a Positron Emission Tomography (PET) Imaging Diagnostic for Alzheimers Disease
10. Safe Blood for Africa Foundation and Hema-Quebec Sign Far-Reaching Agreement
11. COSHAR Foundation Promotes Importance of Timely Childhood Immunization at Black Family Reunion Celebration in Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: